Can microglia negatively impact myelin development in autism?

Gustavo Della-Flora Nunes1

  • 1Department of Cell and Developmental Biology, University of Colorado School of Medicine, 12800 E 19th Ave, RC1 North, Room 7105, MS 8135, Aurora, CO 80045, United States.

Insights

Emerging evidence suggests microglia and oligodendrocytes are involved in autism. Investigating their roles may clarify autism causes and lead to new treatments.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Autism spectrum disorder (ASD) is a complex neurodevelopmental condition.
  • The roles of immune cells and glial cells in ASD pathophysiology are increasingly recognized.
  • Microglia (immune cells of the brain) and oligodendrocytes (myelin-producing cells) are key players.

Purpose of the Study:

  • To review current evidence linking microglia and oligodendrocytes to autism.
  • To explore potential mechanisms by which microglia influence oligodendrocyte function in autism.
  • To highlight the therapeutic potential of targeting these cells for autism.

Main Methods:

  • Comprehensive literature review of preclinical and clinical studies.
  • Analysis of research on glial cell interactions in neurodevelopmental disorders.
  • Synthesis of findings on immune modulation and myelination in autism models.

Main Results:

  • Evidence supports the involvement of both microglia and oligodendrocytes in autism.
  • Microglial activation and dysfunction are implicated in altered brain development.
  • Oligodendrocyte abnormalities, including impaired myelination, are observed in autism.

Conclusions:

  • Microglia may modulate oligodendrocyte function, contributing to autism pathogenesis.
  • Understanding these cellular interactions is crucial for elucidating autism.
  • Targeting microglial and oligodendrocyte pathways offers potential therapeutic strategies for autism phenotypes.

Related Concept Videos